Y-MABS THERAPEUTICS

y-mabs-therapeutics-logo

YmAbs is a clinical stage biopharmaceutical company that discovers and develops innovative treatments for cancer patients through immunotherapies. YmAbs utilizes its platform technologies to create next-generation humanized, affinity matured bispecific antibodies. To further improve its bispecific antibodies, the company collaborates on the development of a novel human protein tag that dimerizes T-cell engaging bispecific antibodies, which enables higher tumor binding and results in a longer ser... um half-life and a significantly greater T-cell mediated killing of tumor cells. YmAbs' treatments claims to potentially reduce longer-term toxicities associated with current chemotherapeutics and provide the potential for curative therapy even for patients with widespread disease. YmAbs’ goal is to drive multiple product candidates in select solid tumor cancers to FDA approval.

#SimilarOrganizations #People #Financial #Website #More

Y-MABS THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Medical Therapeutics

Founded:
2015-04-01

Address:
New York, New York, United States

Country:
United States

Website Url:
http://www.ymabs.com

Total Employee:
51+

Status:
Active

Contact:
1 212 847 9841

Email Addresses:
[email protected]

Total Funding:
338.8 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.


Current Advisors List

laura-hamill_image

Laura Hamill Board Member @ Y-mAbs Therapeutics
Board_member
2020-05-01

Current Employees Featured

not_available_image

Torben Lund-Hansen
Torben Lund-Hansen SVP and Head of Technical Operations @ Y-mAbs Therapeutics
SVP and Head of Technical Operations

not_available_image

Joris Wilms
Joris Wilms COO & SVP @ Y-mAbs Therapeutics
COO & SVP

not_available_image

Claus Moller
Claus Moller CEO @ Y-mAbs Therapeutics
CEO

claus-juan-moller-san-pedro_image

Claus Juan Moller San Pedro
Claus Juan Moller San Pedro CEO and BOD member @ Y-mAbs Therapeutics
CEO and BOD member
2015-10-01

bo-kruse_image

Bo Kruse
Bo Kruse CFO @ Y-mAbs Therapeutics
CFO
2015-05-01

not_available_image

Thomas Gad
Thomas Gad Chairman, Founder, President, and Head of Business Development and Strategy @ Y-mAbs Therapeutics
Chairman, Founder, President, and Head of Business Development and Strategy

not_available_image

Steen Lisby
Steen Lisby SVP & CSO @ Y-mAbs Therapeutics
SVP & CSO

not_available_image

Vignesh Rajah
Vignesh Rajah SVP, CMO & Head of Late-Stage Development @ Y-mAbs Therapeutics
SVP, CMO & Head of Late-Stage Development

Founder


not_available_image

Thomas Gad

Stock Details


Company's stock symbol is NASDAQ:YMAB

Investors List

sofinnova-ventures_image

Sofinnova Investments

Sofinnova Investments investment in Private Equity Round - Y-mAbs Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Private Equity Round - Y-mAbs Therapeutics

scopia-capital_image

Scopia Capital

Scopia Capital investment in Private Equity Round - Y-mAbs Therapeutics

hbm-healthcare-investments-ag_image

HBM Healthcare Investments AG

HBM Healthcare Investments AG investment in Private Equity Round - Y-mAbs Therapeutics

Official Site Inspections

http://www.ymabs.com Semrush global rank: 3.96 M Semrush visits lastest month: 3.14 K

  • Host name: 172.67.138.62
  • IP address: 172.67.138.62
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Y-mAbs Therapeutics" on Search Engine